Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations

Mutations in the BRCA1 and BRCA2 tumour suppressor genes are associated with prostate cancer risk; however, optimal screening protocols for individuals with these mutations have been a subject of debate. Several prospective studies of prostate cancer incidence and screening among BRCA1/2 mutation ca...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Nature reviews. Urology Ročník 20; číslo 4; s. 205 - 216
Hlavní autoři:	Rajwa, Pawel, Quhal, Fahad, Pradere, Benjamin, Gandaglia, Giorgio, Ploussard, Guillaume, Leapman, Michael S, Gore, John L, Paradysz, Andrzej, Tilki, Derya, Merseburger, Axel S, Morgan, Todd M, Briganti, Alberto, Palapattu, Ganesh S, Shariat, Shahrokh F
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Nature Publishing Group 01.04.2023
Témata:	BRCA1 Protein - genetics BRCA2 Protein - genetics Early Detection of Cancer - methods Genes, BRCA1 Genetic Predisposition to Disease Germ Cells - pathology Humans Male Medical screening Mutation Prospective Studies Prostate cancer Prostate-Specific Antigen - genetics Prostatic Neoplasms - diagnosis Prostatic Neoplasms - genetics Prostatic Neoplasms - therapy Quality of Life
ISSN:	1759-4812, 1759-4820, 1759-4820
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!